2 Ablative RadioTherapy Treatments for Prostate Cancer

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

January 29, 2024

Study Completion Date

July 29, 2028

Conditions

Prostate Cancer

Interventions

RADIATION

SABR + HDR

One SABR treatment + one HDR brachytherapy treatment

Trial Locations (1)

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors

lead

Sunnybrook Health Sciences Centre

OTHER

NCT04654338 - 2 Ablative RadioTherapy Treatments for Prostate Cancer | Biotech Hunter | Biotech Hunter